<DOC>
	<DOCNO>NCT01582750</DOCNO>
	<brief_summary>The purpose study determine role endoscopic ultrasound measurement primary tumor maximum diameter change absolute / relative value predict tumor regression concurrent chemoradiotherapy rectal cancer .</brief_summary>
	<brief_title>Endoscopic Ultrasound Predict Sensitivity Stage II / III Rectal Cancer Preoperative Concurrent Chemoradiotherapy</brief_title>
	<detailed_description>We use endoscopic ultrasound measure primary tumor maximum diameter change predict tumor regression concurrent chemoradiotherapy rectal cancer</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>pathologically confirm rectal cancer , preoperative stage II / III ( T34N0 T14N + M0 ) . tumor distance anus le 12 cm . KPS score less 70 tolerate chemotherapy radiotherapy . pelvic history radiation therapy . Nonallergic history fluorouracil platinumbased chemotherapy drug . full understanding study , ability complete treatment plan , follow condition sign inform consent . malignancy ( past time ) , include curable nonmelanoma skin cancer cervical carcinoma situ ; include resectable primary colon cancer ( synchronous metachronous ) . pregnant lactating patient . fertility use contraceptive measure . exist active infection . merge serious complication , tolerate treatment , 6 month myocardial infarction , mental illness , uncontrollable diabetes uncontrollable hypertension hypotension . concurrent treatment anticancer drug . complete treatment followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>endoscopic ultrasound</keyword>
	<keyword>pre-operative concurrent chemoradiotherapy</keyword>
</DOC>